• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
DMXAA

DMXAA

Product ID D509921
Cas No. 117570-53-3
Purity ≥99%
Product Unit SizeCostQuantityStock
5 mg $126.00 In stock
25 mg $288.80 In stock
100 mg $787.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

DMXAA (vadimezan) is a STING (stimulator of interferon genes) agonist. DMXAA triggers the disruption of tumor vasculature, followed by hypoxia and cell death and the release of chemokines. These events lead to tumor regression. While STING agonist activity has accounted for antitumor activity in mice, DMXAA does not bind to human STING. In addition to its antitumor activities. DMXAA has also exhibited antiviral activity.

Product Info

Cas No.

117570-53-3

Purity

≥99%

Formula

C17H14O4

Formula Wt.

282.30

Chemical Name

5,6-Dimethylxantheonone-4-acetic Acid

IUPAC Name

2-(5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid

Synonym

Vadimezan; ASA-404; ASA404; 5,6-Mexaa; NSC 640488

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

D509921 MSDS PDF

Info Sheet

D509921 Info Sheet PDF

References

Weiss JM, Guérin MV, Regnier F.et al, The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression. Oncoimmunology. 2017 6(10):e1346765. doi10.1080/2162402X.2017. PMID: 29123960.

Che X, Du XX, Cai X. et.al., Single Mutations Reshape the Structural Correlation Network of the DMXAA-Human STING Complex. J Phys Chem B. 2017 121(9):2073-2082. PMID: 28178416.

Downey CM, Aghaei M, Schwendener RA. et.al., DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization. PLoS One. 2014 9(6):e99988. PMID: 24940883.

Cerón S, North BJ, Taylor SA, Leib DA. The STING agonist 5,6-dimethylxanthenone-4-acetic acid (DMXAA) stimulates an antiviral state and protects mice against herpes simplex virus-induced neurological disease. Virology. 2019 529:23-28 PMID: 30648635.

Kim S, Li L, et al. Anticancer Flavonoids Are Mouse-Selective STING Agonists. ACS Chem. Biol. 2013 8 (7):1396-1401. DOI: 10.1021/cb400264n PMID: 23683494.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • C0153

    Calcitonin, rat

    Endogenous neuropeptide hormone, lowers extrace...

    ≥95%
  • C1635

    Ceftazidime Hydrate

    β-lactam cephalosporin; penicillin binding pro...

    ≥97%
  • P7033

    Primaquine Phosphate

    Alters membrane permeability, prevents transpor...

    ≥98% (titration)
  • S8012

    [Sar9]-Substance P

    Endogenous tachykinin peptide, involved in infl...

    ≥95%
  • K1653

    Kendomycin

    Macrolide; ET antagonist, proteasome inhibitor....

    ≥98%
  • T1028

    Paclitaxel, 8-Hydro-bicyclo(3.3.0)octane

    Synthesis impurity

    ≥95%
  • B7973

    Busulfan

    Alkyl sulfonate; DNA alkylator.

    ≥98%
  • T6932

    Triflumizole

    Imidazole; PPARγ agonist, RORγ inverse agonis...

    ≥95%
  • V0275

    [Arg8]-Vasotocin

    Peptide, oxytocin-vasopressin analog.

    ≥95%
  • S8251

    Sulfluramid

    Perfluorinated insecticide.

    ≥95%
  • K1978

    Ketorolac Tromethamine

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • A046189

    Abexinostat

    Primarily targets HDAC1

    ≥98%
  • C1633

    Cefotaxime Sodium

    β-lactam cephalosporin; penicillin binding pro...

    ≥96%
  • S7601

    Statil

    Aldose reductase inhibitor.

    ≥98%
  • N8760

    NVP-TAE684

    ALK, c-Fes, LRRK2 inhibitor.

    ≥98%
  • C0261

    Captopril

    ACE inhibitor.

    ≥98%
  • D5868

    Doramapimod

    JNK, ALK, p38 MAPK inhibitor.

    ≥99%
  • M4102

    MK-1775

    Wee1 inhibitor.

    ≥98%
  • E0003

    E64-d

    Cathepsin inhibitor.

    ≥97%
  • S6800

    SR1001

    RORα/γ inverse agonist.

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only